相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B. Escudier et al.
ANNALS OF ONCOLOGY (2014)
Prognostic Value of Diametrically Polarized Tumor-Associated Macrophages in Renal Cell Carcinoma
Le Xu et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
AACR CANCER PROGRESS REPORT 2014 Transforming Lives Through Research
Carlos L. Arteaga et al.
CLINICAL CANCER RESEARCH (2014)
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
Koji Taniguchi et al.
SEMINARS IN IMMUNOLOGY (2014)
Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer
S. Mitsunaga et al.
BRITISH JOURNAL OF CANCER (2013)
IL-11: A Prominent Pro-Tumorigenic Member of the IL-6 Family
Sergei I. Grivennikov
CANCER CELL (2013)
Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted Therapeutically
Tracy L. Putoczki et al.
CANCER CELL (2013)
Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
Payal Kapur et al.
LANCET ONCOLOGY (2013)
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
Lisa M. Coussens et al.
SCIENCE (2013)
Interleukin-6 signaling pathway in targeted therapy for cancer
Yuqi Guo et al.
CANCER TREATMENT REVIEWS (2012)
Inflammation and ovarian cancer
Antonio Maccio et al.
CYTOKINE (2012)
The role of interleukin-6 in gynaecological malignancies
Jermaine I. G. Coward et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2012)
Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5-and 10-year metastasis-free survival
Martin Pichler et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2012)
Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
Hai T. Tran et al.
LANCET ONCOLOGY (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
Maxine Sun et al.
EUROPEAN UROLOGY (2011)
The Anti-Interleukin-6 Antibody Siltuximab Down-Regulates Genes Implicated inTumorigenesis in Prostate Cancer Patients From a Phase I Study
Jayaprakash Karkera et al.
PROSTATE (2011)
Interleukin-11 in Endometrial Adenocarcinoma Is Regulated by Prostaglandin F-2 alpha-F-Prostanoid Receptor Interaction via the Calcium-Calcineurin-Nuclear Factor of Activated T Cells Pathway and Negatively Regulated by the Regulator of Calcineurin-1
Kurt J. Sales et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer
Yuqi Guo et al.
CLINICAL CANCER RESEARCH (2010)
More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer
Tracy Putoczki et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Presence of Intratumoral Neutrophils Is an Independent Prognostic Factor in Localized Renal Cell Carcinoma
Hanne Krogh Jensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cytokines as a key component of cancer-related inflammation
Giovanni Germano et al.
CYTOKINE (2008)
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival
G Bellone et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer
S Bellone et al.
GYNECOLOGIC ONCOLOGY (2005)
Leukaemia inhibitory factor (LIF) is immunohistochemically expressed in normal, hyperplastic and malignant endometrial tissue
L Mylonas et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2005)
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma - A stratification tool for prospective clinical trials
BC Leibovich et al.
CANCER (2003)
分享论文
